Fueled by an urgent need for diagnostic testing to respond to COVID-19, the in-vitro diagnostics market is experiencing explosive growth across Asia and around the globe.
Across Asia, government health and safety authorities have tightened regulations on medical devices this year, as markets continue to experience rapid change, and as the devices themselves gain sophistication and complexity at a blistering pace.
In general, the Asian markets have controlled the COVID-19 virus successfully outside of China, but its effect has still led to new developments and trends.
These countries have been more successful with managing the virus than the United States and the European Union.
COVID-19 is driving patients to seek telehealth solutions, and it won’t be a short-term boom.
The immense challenges posed by the coronavirus pandemic are fueling interest in cloud computing among vaccine researchers, clinicians, healthcare companies and patients across Asia.
From artificial intelligence to autonomous sterilization robots to drones, emerging technologies are playing a strong role in combating COVID-19.
The Chinese government is investing heavily in the development of new technologies that leverage AI. This includes solutions to address the COVID-19 outbreak.
A more comprehensive management approach is needed to tackle the rising threat of diabetes in the region.
Across the continent, governments and hospitals are purchasing robotics systems from abroad as well as developing the technologies themselves.